Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HZ3Q
|
||||
Drug Name |
AGN-190383
|
||||
Synonyms |
120755-15-9; AGN-190383
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Unspecified | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H32O5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Phospholipase A2 | Target Info | Modulator | ||
BioCyc Pathway | Phospholipases | ||||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Ether lipid metabolism | |||||
Arachidonic acid metabolism | |||||
Linoleic acid metabolism | |||||
alpha-Linolenic acid metabolism | |||||
Metabolic pathways | |||||
Ras signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Pancreatic secretion | |||||
Fat digestion and absorption | |||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | ||||
Reactome | Acyl chain remodelling of PC | ||||
Acyl chain remodelling of PE | |||||
Acyl chain remodelling of PI | |||||
WikiPathways | Glycerophospholipid biosynthesis | ||||
References | |||||
REF 1 | AGN 190383, a novel phospholipase inhibitor with topical anti-inflammatory activity. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.